Ripple:将常规患者报告的生活质量评估引入南澳大利亚儿科肿瘤学实践

IF 6.5 1区 医学 Q1 ONCOLOGY International Journal of Radiation Oncology Biology Physics Pub Date : 2025-03-01 Epub Date: 2025-02-03 DOI:10.1016/j.ijrobp.2024.11.014
M. Doig , S. Jessop , J. Hansford , H. Le , P. Gorayski , A. Cunningham , A. Hutchinson , M. O'Connor , V. Bedford , E. Bezak , N. Parange , K. Skelton , T. Price , M. Short
{"title":"Ripple:将常规患者报告的生活质量评估引入南澳大利亚儿科肿瘤学实践","authors":"M. Doig ,&nbsp;S. Jessop ,&nbsp;J. Hansford ,&nbsp;H. Le ,&nbsp;P. Gorayski ,&nbsp;A. Cunningham ,&nbsp;A. Hutchinson ,&nbsp;M. O'Connor ,&nbsp;V. Bedford ,&nbsp;E. Bezak ,&nbsp;N. Parange ,&nbsp;K. Skelton ,&nbsp;T. Price ,&nbsp;M. Short","doi":"10.1016/j.ijrobp.2024.11.014","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>Health-Related Quality of Life (HRQoL) assessment of children with cancer is not routinely performed in South Australia. Our goal was to co-design and evaluate a digital platform ‘Ripple’ for HRQoL collection and real-time clinical actioning in young patients.</div></div><div><h3>Methods</h3><div>Study 1 involved platform co-design with children, parents, and multi-disciplinary health professionals. The Ripple platform hosts validated PedsQL Generic Core score patient-reported outcome measures (PROMs) in child self-report and parent-proxy versions for children aged 5-12 years. Study 2 involved a 12-month multi-site hybrid implementation-effectiveness study to test the digital platform's feasibility in South Australian paediatric oncology and radiation oncology services. Children aged 5-12 years receiving treatment or follow-up care, a parent and their healthcare team were invited. Children and parents completed PROMs remotely or in clinic to align with clinical milestones. Clinicians were instantaneously notified of results. Preliminary results from Study 2 are presented.</div></div><div><h3>Results</h3><div>Study 1 included 20 participants (seven children, four parents and nine clinicians). In Study 2, 65 participants were recruited, including 28 children, 27 parents and 10 healthcare professionals. 54% of children were female and the median age at recruitment was 7 years. Children were diagnosed with a haematological malignancy (n=19), extracranial solid tumour (n=6) or central nervous system tumour (n=3). Compliance of children and parents completing the scheduled PROMs was 100% and 86%, respectively. Seven of nine clinicians had engaged with the PROM results. Of note, six patients required clinical follow-up based on a PROM entry due to emotional functioning responses (n=6), very low total score (n=2) or a significant decline from previous entry (n=2).</div></div><div><h3>Conclusion</h3><div>Early results show that patient-reported HRQoL assessment using a child-friendly digital platform is feasible in paediatric oncology clinical practice. Further research is needed to investigate whether PedsQL can support psychosocial assessment in this cohort.</div></div>","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":"121 3","pages":"Page e2"},"PeriodicalIF":6.5000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Ripple: Introducing Routine Patient-Reported Quality of Life Assessment into South Australian Pediatric Oncology Practice\",\"authors\":\"M. Doig ,&nbsp;S. Jessop ,&nbsp;J. Hansford ,&nbsp;H. Le ,&nbsp;P. Gorayski ,&nbsp;A. Cunningham ,&nbsp;A. Hutchinson ,&nbsp;M. O'Connor ,&nbsp;V. Bedford ,&nbsp;E. Bezak ,&nbsp;N. Parange ,&nbsp;K. Skelton ,&nbsp;T. Price ,&nbsp;M. Short\",\"doi\":\"10.1016/j.ijrobp.2024.11.014\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><div>Health-Related Quality of Life (HRQoL) assessment of children with cancer is not routinely performed in South Australia. Our goal was to co-design and evaluate a digital platform ‘Ripple’ for HRQoL collection and real-time clinical actioning in young patients.</div></div><div><h3>Methods</h3><div>Study 1 involved platform co-design with children, parents, and multi-disciplinary health professionals. The Ripple platform hosts validated PedsQL Generic Core score patient-reported outcome measures (PROMs) in child self-report and parent-proxy versions for children aged 5-12 years. Study 2 involved a 12-month multi-site hybrid implementation-effectiveness study to test the digital platform's feasibility in South Australian paediatric oncology and radiation oncology services. Children aged 5-12 years receiving treatment or follow-up care, a parent and their healthcare team were invited. Children and parents completed PROMs remotely or in clinic to align with clinical milestones. Clinicians were instantaneously notified of results. Preliminary results from Study 2 are presented.</div></div><div><h3>Results</h3><div>Study 1 included 20 participants (seven children, four parents and nine clinicians). In Study 2, 65 participants were recruited, including 28 children, 27 parents and 10 healthcare professionals. 54% of children were female and the median age at recruitment was 7 years. Children were diagnosed with a haematological malignancy (n=19), extracranial solid tumour (n=6) or central nervous system tumour (n=3). Compliance of children and parents completing the scheduled PROMs was 100% and 86%, respectively. Seven of nine clinicians had engaged with the PROM results. Of note, six patients required clinical follow-up based on a PROM entry due to emotional functioning responses (n=6), very low total score (n=2) or a significant decline from previous entry (n=2).</div></div><div><h3>Conclusion</h3><div>Early results show that patient-reported HRQoL assessment using a child-friendly digital platform is feasible in paediatric oncology clinical practice. Further research is needed to investigate whether PedsQL can support psychosocial assessment in this cohort.</div></div>\",\"PeriodicalId\":14215,\"journal\":{\"name\":\"International Journal of Radiation Oncology Biology Physics\",\"volume\":\"121 3\",\"pages\":\"Page e2\"},\"PeriodicalIF\":6.5000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Radiation Oncology Biology Physics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0360301624035880\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/3 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Radiation Oncology Biology Physics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0360301624035880","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/3 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

在南澳大利亚,与健康相关的生活质量(HRQoL)评估在儿童癌症患者中并不常见。我们的目标是共同设计和评估用于年轻患者HRQoL收集和实时临床行动的数字平台“Ripple”。方法研究1与儿童、家长和多学科卫生专业人员共同设计平台。Ripple平台对5-12岁儿童的儿童自我报告和家长代理版本的PedsQL Generic Core评分患者报告的结果测量(PROMs)进行了验证。研究2涉及一项为期12个月的多地点混合实施有效性研究,以测试数字平台在南澳大利亚儿科肿瘤学和放射肿瘤学服务中的可行性。邀请5-12岁接受治疗或后续护理的儿童,家长及其医疗团队。儿童和家长远程或在诊所完成PROMs,以配合临床里程碑。临床医生被即时通知结果。本文给出了研究2的初步结果。研究1包括20名参与者(7名儿童、4名家长和9名临床医生)。在研究2中,招募了65名参与者,包括28名儿童,27名家长和10名医疗保健专业人员。54%的儿童为女性,入职时的中位年龄为7岁。儿童被诊断为血液系统恶性肿瘤(n=19),颅外实体瘤(n=6)或中枢神经系统肿瘤(n=3)。儿童和家长完成预定prom的依从性分别为100%和86%。9名临床医生中有7名参与了PROM的结果。值得注意的是,有6名患者由于情绪功能反应(n=6)、总分很低(n=2)或较前一次评分明显下降(n=2)而需要进行临床随访。结论早期结果表明,采用儿童友好型数字平台进行患者报告的HRQoL评估在儿科肿瘤临床实践中是可行的。PedsQL是否可以支持该队列的心理社会评估,还需要进一步的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Ripple: Introducing Routine Patient-Reported Quality of Life Assessment into South Australian Pediatric Oncology Practice

Objectives

Health-Related Quality of Life (HRQoL) assessment of children with cancer is not routinely performed in South Australia. Our goal was to co-design and evaluate a digital platform ‘Ripple’ for HRQoL collection and real-time clinical actioning in young patients.

Methods

Study 1 involved platform co-design with children, parents, and multi-disciplinary health professionals. The Ripple platform hosts validated PedsQL Generic Core score patient-reported outcome measures (PROMs) in child self-report and parent-proxy versions for children aged 5-12 years. Study 2 involved a 12-month multi-site hybrid implementation-effectiveness study to test the digital platform's feasibility in South Australian paediatric oncology and radiation oncology services. Children aged 5-12 years receiving treatment or follow-up care, a parent and their healthcare team were invited. Children and parents completed PROMs remotely or in clinic to align with clinical milestones. Clinicians were instantaneously notified of results. Preliminary results from Study 2 are presented.

Results

Study 1 included 20 participants (seven children, four parents and nine clinicians). In Study 2, 65 participants were recruited, including 28 children, 27 parents and 10 healthcare professionals. 54% of children were female and the median age at recruitment was 7 years. Children were diagnosed with a haematological malignancy (n=19), extracranial solid tumour (n=6) or central nervous system tumour (n=3). Compliance of children and parents completing the scheduled PROMs was 100% and 86%, respectively. Seven of nine clinicians had engaged with the PROM results. Of note, six patients required clinical follow-up based on a PROM entry due to emotional functioning responses (n=6), very low total score (n=2) or a significant decline from previous entry (n=2).

Conclusion

Early results show that patient-reported HRQoL assessment using a child-friendly digital platform is feasible in paediatric oncology clinical practice. Further research is needed to investigate whether PedsQL can support psychosocial assessment in this cohort.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
11.00
自引率
7.10%
发文量
2538
审稿时长
6.6 weeks
期刊介绍: International Journal of Radiation Oncology • Biology • Physics (IJROBP), known in the field as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both education and health policy as it relates to the field. This journal has a particular interest in original contributions of the following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying cancer and normal tissue radiation response.
期刊最新文献
Effects of Nutritional Interventions on Quality of Life in Patients with Nasopharyngeal Carcinoma Undergoing Radiation Therapy Based on Dynamic Nutritional Risk Screening and Assessment: An Open-Label Single-Center Randomized Phase 3 Trial Low-Dose External Beam Radiation Therapy and Painful Hip Due to Coxarthrosis and Greater Trochanteric Pain Syndrome: Predictive Impact of Diagnosis, Target Volume Definition, and Season of Treatment Proton Beam Therapy for Intrahepatic and Perihilar Cholangiocarcinoma: A Multicenter Prospective Registry Study: Potential Candidates for High-Dose Proton Beam Therapy Incorporating Individual Early Response in the Dose-Effect Relationship of Complete Pathological Response Following Neoadjuvant Radiochemotherapy for Rectal Cancer Use of Magnetic Resonance Imaging to Guide Preoperative Accelerated Partial Breast Irradiation in the Prone Position and Treatment Response in Clinical Stage 1 Hormone Sensitive Breast Cancer: A Phase 1/2 Study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1